Institution statistics

OSPEDALE SAN RAFFAELE - Italy 

Ranking results:

Past rankings:
2018
Criterium:Position:
Overall Score:200-300
Total Project Funding per Partner:200-300
Total Number of Projects:100-200
Networking Rank (Reputation):400-500
2017
Criterium:Position:
Overall Score:200-300
Total Project Funding per Partner:100-200
Total Number of Projects:200-300
Networking Rank (Reputation):300-400
2016
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2015
Criterium:Position:
Overall Score:800-900
Total Project Funding per Partner:300-400
Total Number of Projects:800-900
Networking Rank (Reputation):> 1000
Partner Constancy:500-600
Project Leadership Index:500-600
2012
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
Networking Rank (Reputation):> 1000
Ranking timeline:

European project participation (2000-01-01 - 2020-12-31 ):

Performance:

Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:
Leadership:

Total number of projects: 63
As coordinator: 6
As participant: 43
Sole participant: 14
Coordinator / Participant Ratio: 0.14*

*Ratio includes only projects with > 2 partners

Summary:
Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2020 1.499.563 25.671.293 3.956.812 1 5
2019 2.835.876 30.150.625 3.907.126 6 3
2018 6.512.394 40.283.115 7.297.447 6 8
2017 1.833.548 49.906.125 6.933.937 3 8
2016 0 16.730.732 1.600.050 3
2015 0 30.801.022 3.522.939 3
2014 0 4.166.914 3.746.414 2
2012 0 6.000.000 375.000 1
2011 100.000 2.980.000 154.450 1 1
2010 100.000 30.008.500 2.633.522 1 8
2009 200.000 0 100.000 2
2008 0 1.435.140 717.570 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:
Institution:Projects [No]:
FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR18
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE6
UNIVERSITY COLLEGE LONDON6
ACADEMISCH ZIEKENHUIS LEIDEN5
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM4
KAROLINSKA INSTITUTE4
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN4
MILTENYI BIOTEC4
UNIVERSITA DEGLI STUDI DI MILANO4
CHARITE UNIVERSITAETSMEDIZIN BERLIN3
COMMISSARIAT A L'ENERGIE ATOMIQUE3
KATHOLIEKE UNIVERSITEIT LEUVEN3
POLITECNICO DI MILANO3
STICHTING KATHOLIEKE UNIVERSITEIT3
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD3
UNIVERSITA DEGLI STUDI DI VERONA3
UNIVERSITAETSKLINIKUM FREIBURG3
UNIVERSITY OF BOLOGNA3
UNIVERSITY OF SOUTHAMPTON3
VRIJE UNIVERSITEIT BRUSSEL3
ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM2
ACADEMISCH ZIEKENHUIS MAASTRICHT2
ARTTIC2
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS2
BUNDESINSTITUT FUR IMPFSTOFFE UND BIOMEDIZINISCHE ARZNEIMITTEL2
CENTRE EUROPEEN DE RECHERCHE EN BIOLOGIE ET MEDECINE2
CENTRE HOSPITALIER REGIONAL ET UNIVERSITAIRE DE LILLE2
CONSIGLIO NAZIONALE DELLE RICERCHE2
EBERHARD KARLS UNIVERSITAET TUEBINGEN2
ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE2
FUNDACIO HOSPITAL UNIVERSITARI VALL D'HEBRON INSTITUT DE RECERCA2
FUNDACIO INSTITUT DE BIOENGINYERIA DE CATALUNYA2
GENEWERK2
GREAT ORMOND STREET HOSPITAL FOR CHILDREN NHS FOUNDATION TRUST2
IBM ISRAEL SCIENCE AND TECHNOLOGY2
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE2
INSTITUT CATALA DE LA SALUT2
INSTITUTO DE SALUD CARLOS III2
INTERNATIONAL PATIENT ORGANISATION FOR PRIMARY IMMUNODEFICIENCIES2
ISTITUTO SUPERIORE DI SANITA2
KING'S COLLEGE LONDON2
KUNGLIGA TEKNISKA HOEGSKOLAN2
MEDIZINISCHE HOCHSCHULE HANNOVER2
NESTEC2
OSPEDALE PEDIATRICO BAMBINO GESU2
POLITECNICO DI TORINO2
REGION HOVEDSTADEN2
TALLINNA TEHNIKAULIKOOL2
THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA CORP2
UNIVERSITA DEGLI STUDI DEL PIEMONTE ORIENTALE AMEDEO AVOGADRO2
UNIVERSITAET ULM2
UNIVERSITY OF AARHUS2
UNIVERSITY OF COPENHAGEN2
UNIVERSITY OF NEWCASTLE UPON TYNE2
UNIVERSITY OF OSLO2
WESTFAELISCHE WILHELMSUNIVERSITAET MUENSTER2
ACADEMISCH ZIEKENHUIS GRONINGEN1
ACCELOPMENT1
ACMIT1
ACROMION1
ADAPTIMMUNE LIMITED1
ADVANCED PRACTICAL DIAGNOSTICS1
AGENCIA DE QUALITAT I AVALUACIO SANITARIES DE CATALUNYA1
AIBILI ASSOCIACAO PARA INVESTIGACAO BIOMEDICA E INNOVACAO EM LUZ E IMAGEM1
ALDEBARAN ROBOTICS SAS1
ALPES LASERS1
ALTIUS INSTITUTE FOR BIOMEDICAL SCIENCES1
ALZHEIMER EUROPE1
AMSTERDAM BIOTHERAPEUTICS UNIT1
ANAXOMICS BIOTECH S L1
ANYSOLUTION SL1
ARGOS MESSTECHNIK1
ASCEND TECHNOLOGIES LIMITED1
ASOCIACION MADRID PLATAFORMA DE LA BIOTECNOLOGIA1
ASPETE HIGHER SCHOOL OF PEDAGOGIC & TECHNOLOGICAL EDUCATION1
ASSOCIATION FONDATION INTERNET NOUVELLE GENERATION AFING1
ASSOCIATION MARIE LANNELONGUE1
ATOS SPAIN1
AYUNTAMIENTO DE CALVIA1
AZIENDA OSPEDALIEROUNIVERSITARIA MAGGIORE DELLA CARITA NOVARA1
BALTIC INNOVATION AGENCY OUE1
BARTS AND THE LONDON NHS TRUST1
BATAVIA BIOSCIENCES BV1
BAYLOR COLLEGE OF MEDICINE1
BIBA BREMER INSTITUT FUER PRODUKTION UND LOGISTIK1
BIOCOMPUTING PLATFORMS LTD OY1
BIOMECA1
BIONTECH RNA PHARMACEUTICALS1
BIOWIN ASBL1
CAIRN RESEARCH LIMITED1
CAREERS RESEARCH AND ADVISORY CENTRE LIMITED1
CELL NETWORKS1
CELLULAR THERAPEUTICS LIMITED1
CENTER FOR BETA CELL THERAPY IN DIABETES1
CENTRE HOSPITALIER UNIVERSITAIRE DE GRENOBLE1
CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS1
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE1
CF CONSULTING FINANZIAMENTI UNIONE EUROPEA1
CHU HOPITAUX DE BORDEAUX1
CIMAAS BV1
Constancy:

Total number of partners:455

Partner loyalty:
Frequent Partner: (> 2 projects): 88
Rare Partner: 367

Frequent / Rare Partner Ratio: 0.24

Diversity:

Categories:
Category:No:
RTD HORIZONTAL TOPICS9
BIOLOGICAL SCIENCES6
INDUSTRY AND TECHNOLOGY5
SOCIAL AND ECONOMIC CONCERNS4

Project overview:

Start dateProjectacronymrolefundingpartners
2020-06-01Endosomal control of local protein synthesis in axons AXONENDOcoordinator1.499.5631
2020-01-01New Generation Cell Therapy: Bioartificial Pancreas to Cure Type 1 Diabetes VANGUARDparticipant6.844.6259
2020-01-01INnovative Training in Myeloid Regulatory Cell Therapy INsTRuCTparticipant4.021.02713
2020-01-01Retinal and cognitive dysfunction in type 2 diabetes: unraveling the common pathways and identification of patients at risk of dementia RECOGNISEDparticipant5.998.27321
2020-01-01Human Cell Atlas of the Pancreas ESPACEparticipant4.962.49510
2020-01-01Studying Ciliary Signaling in Development and Disease SCilSparticipant3.844.87410
2019-09-01HIstory and IMpact of NEUROimaging on SOCIETY HI_IM_NEUROSOCIETYcoordinator168.2771
2019-08-01Microfluidic chambers for establishing physiological and pathological human iPSC-derived neuronal circuits BrainCircuit-on-chipcoordinator150.0002
2019-06-03"""Investigating autophagy enhancement as a therapeutic approach for the treatment of Rett syndrome.""" RTTOPHAGYcoordinator171.4731
2019-06-01Development of gene therapy and genome editing strategies to treat adenosine deaminase 2 deficiency DADA2GTcoordinator183.4731
2019-03-01Dissecting and Overcoming Innate Immune Barriers for Therapeutically Efficient Hematopoietic Stem Cell Gene Engineering ImmunoStemcoordinator1.994.3751
2019-02-01Uncovering the origin and mechanisms of Down syndrome-associated leukaemia through human induced pluripotent stem cell-derived haemopoiesis LEUKEYOLKcoordinator168.2771
2019-01-01Data-protection toolkit reducing risks in hospitals and care centers ProTegoparticipant4.457.7239
2019-01-01Biomechanics in health and disease: advanced physical tools for innovative early diagnosis Phys2BioMedparticipant3.911.78316
2019-01-01Citizen-centred EU-EHR exchange for personalised health Smart4Healthparticipant21.781.12019
2018-12-01Platform for Innovation of Procurement and Procurement of Innovation PIPPIparticipant2.996.0008
2018-11-01Predictive Epigenetics: Fusing Theory and Experiment PEP-NETparticipant4.062.70016
2018-11-01Fact-based personalised nutrition for the young NUTRISHIELDparticipant7.197.09616
2018-10-01Novel precision technological platforms to promote non-invasive early diagnosis, eradicationand prevention of cancer relapse: proof of concept in the bladder carcinoma. EDITcoordinator4.317.1609
2018-10-01Training on Advanced Stem Cell Technologies in Neurology ASCTN-Trainingparticipant3.749.40311
2018-09-01IMaging Pancreatic Alpha-cells Calcium Tied with HEterogeneous Analysis of Labeled Transcription factors with in situ Hybridization IMPACT-HEALTHcoordinator168.2771
2018-07-02Can human embryo-released extracellular vesicles govern endometrial receptivity and inform on vanguard embryo diagnostics and fertility therapeutics? CERVINOcoordinator180.2771
2018-05-16Patroller monocytes as modulators of diabetic retinopathy PAMpeRcoordinator180.2771
2018-03-01Dissecting Cross-Regulatory Interplays in Tumor-Associated Macrophages X-TAMcoordinator1.498.1251
2018-03-01Investigating the effects of immunogenic chemoradiation in shaping the immune landscape of esophageal cancers IC_IL_EC_2017coordinator168.2771
2018-01-01SLAMF7-CAR T cells prepared by Sleeping Beauty gene-transfer for immunotherapy of multiple myeloma – a rare hematologic disease CARAMBAparticipant6.097.87510
2018-01-01Immune Signatures for Therapy Stratification in Major Mood Disorders MOODSTRATIFICATIONparticipant5.963.75012
2018-01-01Smart Autonomous Robotic Assistant Surgeon SARASparticipant4.225.8319
2018-01-01Stem-cell based gene therapy for recombination deficient SCID (RECOMB) RECOMBparticipant5.990.46017
2017-12-01Soraprazan - a new regenerative therapy for Stargardt's disease Soraprazanparticipant5.792.4257
2017-11-01Smart-Taylored L-category Electric Vehicle demonstration in hEtherogeneous urbanuse-cases STEVEparticipant7.429.67522
2017-07-01Functional Biology of Hepatic CD8+ T cells FATEparticipant2.390.0001
2017-07-01Spatiotemporal dynamics of CD8+ T cell responses to hepatocellular carcinoma Hepatocarcinoma IVMcoordinator168.2771
2017-05-01Epigenetic approach for the treatment of obesity EASYcoordinator168.2771
2017-04-01Tracking and predicting neurodegeneration spreading across the brain connectome NeuroTRACKcoordinator1.496.9941
2017-02-01Molecule-to-man pain network PAIN-Netparticipant3.335.31612
2017-01-01EURopean Endeavour for Chimeric Antigen Receptor Therapies EURE-CARTparticipant5.903.1469
2017-01-01Paraplegia Prevention in Aortic Aneurysm Repair by Thoracoabdominal Staging with ‘Minimally-Invasive Segmental Artery Coil-Embolization’: A Randomized Controlled Multicentre Trial PAPA-ARTISparticipant5.913.92326
2017-01-01DITAS: Data-intensive applications Improvement by moving daTA and computation in mixed cloud/fog environmentS DITASparticipant4.420.1888
2017-01-01Multiple manifestations of genetic and non-genetic factors in Multiple Sclerosis disentangled with a multi-omics approach to accelerate personalised medicine MultipleMSparticipant14.721.45322
2016-11-01Smart optical and ultrasound diagnostics of breast cancer SOLUSparticipant3.815.2609
2016-01-01Chimeric Antigen Receptors (CARs) for Advanced Therapies CARATparticipant5.989.1598
2016-01-01DevelopIng Genetic medicines for Severe Combined Immunodeficiency (SCID) SCIDNETparticipant6.926.31312
2015-12-01Beta Cell Generation by Stem Cell-Derived Implants in Diabetes BetaCellTherapyparticipant6.200.0008
2015-11-01European AIDS Vaccine Initiative 2020 EAVI2020participant22.948.02226
2015-01-01Neurovascular Interactions and Pathfinding in the Spinal Motor System NEVAIparticipant1.653.0001
2014-06-01HSC-based therapies for LSDs: understanding the modalities of cell replacement in the LSD brain for improving therapeutic efficacy HSCSFORLSDBRAINparticipant1.751.1471
2014-06-01New experimental therapeutic approaches for Parkinson’s disease by direct DA neuronal reprogramming REPROPARKparticipant2.415.7672
2012-12-01Adoptive engineered T cell Trials to Achieve Cancer Killing ATTACKparticipant6.000.00016
2011-04-01Effect of PTPN22 on Treg to Teff equilibrium in human and murine autoimmune diabetes PTPN22 in T1Dcoordinator100.0002

overview shows latest 50 from 63 projects (2000-01-01 - 2020-12-31)
A full list of projects can be found here:
Data provision: © European Union; Source: CORDIS, http://cordis.europa.eu/ | This page is not provided by the European Commission see:Impressum